Traders sold shares of Monsanto (NYSE:MON) on strength during trading on Friday. $39.02 million flowed into the stock on the tick-up and $74.37 million flowed out of the stock on the tick-down, for a money net flow of $35.35 million out of the stock. Of all companies tracked, Monsanto had the 22nd highest net out-flow for the day. Monsanto traded up $0.51 for the day and closed at $116.78
A number of research analysts have recently commented on the company. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a report on Monday, December 11th. Royal Bank of Canada reissued a “hold” rating and set a $128.00 price target on shares of Monsanto in a report on Wednesday, November 15th. Wells Fargo & Co raised their price target on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday, October 10th. Barclays reissued an “equal weight” rating and set a $124.00 price target (up from $120.00) on shares of Monsanto in a report on Thursday, October 5th. Finally, BMO Capital Markets reissued a “buy” rating and set a $128.00 price target on shares of Monsanto in a report on Thursday, October 5th. Twelve research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Monsanto has a consensus rating of “Hold” and an average target price of $124.61.
The company has a market cap of $51,291.58, a P/E ratio of 22.85, a price-to-earnings-growth ratio of 1.67 and a beta of 1.04. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12.
The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be paid a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, January 4th. This represents a $2.16 annualized dividend and a yield of 1.85%. Monsanto’s dividend payout ratio is currently 42.27%.
In related news, CFO Pierre Courduroux sold 4,320 shares of the firm’s stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $122.00, for a total transaction of $527,040.00. Following the completion of the transaction, the chief financial officer now owns 48,388 shares of the company’s stock, valued at $5,903,336. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Steven Mizell sold 11,526 shares of the firm’s stock in a transaction dated Monday, October 9th. The shares were sold at an average price of $119.70, for a total value of $1,379,662.20. The disclosure for this sale can be found here. Insiders have sold 23,736 shares of company stock valued at $2,871,255 in the last ninety days. Company insiders own 0.79% of the company’s stock.
Hedge funds have recently made changes to their positions in the stock. Bruderman Asset Management LLC acquired a new position in shares of Monsanto in the 2nd quarter valued at $116,000. Tower Research Capital LLC TRC boosted its position in shares of Monsanto by 230.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after purchasing an additional 750 shares during the period. Americafirst Capital Management LLC acquired a new position in shares of Monsanto in the 3rd quarter valued at $148,000. Penserra Capital Management LLC boosted its position in shares of Monsanto by 13.0% in the 2nd quarter. Penserra Capital Management LLC now owns 1,456 shares of the basic materials company’s stock valued at $172,000 after purchasing an additional 168 shares during the period. Finally, Fieldpoint Private Securities LLC boosted its position in shares of Monsanto by 100.6% in the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,575 shares of the basic materials company’s stock valued at $186,000 after purchasing an additional 790 shares during the period. 75.45% of the stock is owned by institutional investors and hedge funds.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
What are top analysts saying about Monsanto? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Monsanto and related companies.